We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Vaccine Developed Against Bioterrorism Toxin

By Biotechdaily staff writers
Posted on 13 Sep 2002
Researchers have developed a vaccine in mice against ricin, a deadly toxin produced from castor beans that has been used as a biologic weapon in many parts of the world. Their work was reported in the September 10, 2002, issue of Vaccine.

In creating the new vaccine, researchers from the University of Texas Southwestern Medical Center (UT, Dallas, USA) mutated the DNA encoding the active A chain of the toxin. They took out the site that inhibits protein synthesis as well as the site responsible for inducing vascular leak. They then created three recombinant versions of ricin A chain, two of which were effective as vaccine in mice. The researchers believe one or both of these would be safe and effective in humans.

"Ricin is not only dangerous, but it is also cheap and easy to make,” said Dr. Ellen Vitetta, director of the Cancer Immunology Center at UT Southwestern and senior author of the study. Large stockpiles of ricin have been found in several countries in the Middle East, she noted.




Related Links:
Univ. of Texas Southwestern

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Chromogenic Culture System
InTray™ COLOREX™ ECC

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
13 Sep 2002  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
13 Sep 2002  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
13 Sep 2002  |   BioResearch